These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 36622529

  • 1. Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809).
    Gholami S, Colby S, Horowitz DP, Guthrie KA, Ben-Josef E, El-Khoueiry AB, Blanke CD, Philip PA, Kachnic LA, Ahmad SA, Rocha FG.
    Ann Surg Oncol; 2023 Mar; 30(3):1354-1363. PubMed ID: 36622529
    [Abstract] [Full Text] [Related]

  • 2. The role of surgery and adjuvant therapy in lymph node-positive cancers of the gallbladder and intrahepatic bile ducts.
    Tran Cao HS, Zhang Q, Sada YH, Chai C, Curley SA, Massarweh NN.
    Cancer; 2018 Jan 01; 124(1):74-83. PubMed ID: 28841223
    [Abstract] [Full Text] [Related]

  • 3. SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma.
    Ben-Josef E, Guthrie KA, El-Khoueiry AB, Corless CL, Zalupski MM, Lowy AM, Thomas CR, Alberts SR, Dawson LA, Micetich KC, Thomas MB, Siegel AB, Blanke CD.
    J Clin Oncol; 2015 Aug 20; 33(24):2617-22. PubMed ID: 25964250
    [Abstract] [Full Text] [Related]

  • 4. Adjuvant Chemoradiation in Resected Biliary Adenocarcinoma: Evaluation of SWOG S0809 with a Large National Database.
    Dominguez DA, Wong P, Chen YJ, Singh GP, Fong Y, Li D, Ituarte PHG, Melstrom LG.
    Ann Surg Oncol; 2024 Aug 20; 31(8):4896-4904. PubMed ID: 38443700
    [Abstract] [Full Text] [Related]

  • 5. Outcome of adjuvant therapy in biliary tract cancers.
    McNamara MG, Walter T, Horgan AM, Amir E, Cleary S, McKeever EL, Min T, Wallace E, Hedley D, Krzyzanowska M, Moore M, Gallinger S, Greig P, Serra S, Dawson LA, Knox JJ.
    Am J Clin Oncol; 2015 Aug 20; 38(4):382-7. PubMed ID: 24572429
    [Abstract] [Full Text] [Related]

  • 6. Adjuvant concurrent chemoradiation therapy in patients with microscopic residual tumor after curative resection for extrahepatic cholangiocarcinoma.
    Lee J, Kang SH, Noh OK, Chun M, Oh YT, Kim BW, Kim SW.
    Clin Transl Oncol; 2018 Aug 20; 20(8):1011-1017. PubMed ID: 29256155
    [Abstract] [Full Text] [Related]

  • 7. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies.
    Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, Wagman R, Blumgart LH, Fong Y.
    Cancer; 2003 Oct 15; 98(8):1689-700. PubMed ID: 14534886
    [Abstract] [Full Text] [Related]

  • 8. Adequate lymph node assessment for extrahepatic bile duct adenocarcinoma.
    Ito K, Ito H, Allen PJ, Gonen M, Klimstra D, D'Angelica MI, Fong Y, DeMatteo RP, Brennan MF, Blumgart LH, Jarnagin WR.
    Ann Surg; 2010 Apr 15; 251(4):675-81. PubMed ID: 20224368
    [Abstract] [Full Text] [Related]

  • 9. Role of adjuvant (chemo)radiotherapy for resected extrahepatic cholangiocarcinoma: a meta-analysis.
    Shi XQ, Zhang JY, Tian H, Tang LN, Li AL.
    J Zhejiang Univ Sci B; 2020 Jul 15; 21(7):549-559. PubMed ID: 32633109
    [Abstract] [Full Text] [Related]

  • 10. A meta-analysis of the efficacy of postoperative adjuvant radiotherapy versus no radiotherapy for extrahepatic cholangiocarcinoma and gallbladder carcinoma.
    Ren B, Guo Q, Yang Y, Liu L, Wei S, Chen W, Tian Y.
    Radiat Oncol; 2020 Jan 15; 15(1):15. PubMed ID: 31941520
    [Abstract] [Full Text] [Related]

  • 11. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
    Zhu J, Liu C, Li H, Ren H, Cai Y, Lan T, Wu H.
    Cancer Med; 2023 Apr 15; 12(7):8184-8198. PubMed ID: 36645113
    [Abstract] [Full Text] [Related]

  • 12. Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma.
    Kelly KJ, Dukleska K, Kuk D, Kingham TP, D'Angelica MI, DeMatteo RP, Allen PJ, Jarnagin WR, Fong Y.
    Ann Surg Oncol; 2014 Mar 15; 21(3):979-85. PubMed ID: 24212720
    [Abstract] [Full Text] [Related]

  • 13. Diagnostic and Prognostic Role of 18-FDG PET/CT in the Management of Resectable Biliary Tract Cancer.
    Ma KW, Cheung TT, She WH, Chok KSH, Chan ACY, Dai WC, Chiu WH, Lo CM.
    World J Surg; 2018 Mar 15; 42(3):823-834. PubMed ID: 28905105
    [Abstract] [Full Text] [Related]

  • 14. Survival benefit with adjuvant radiotherapy after resection of distal cholangiocarcinoma: A propensity-matched National Cancer Database analysis.
    Kamarajah SK, Bednar F, Cho CS, Nathan H.
    Cancer; 2021 Apr 15; 127(8):1266-1274. PubMed ID: 33320344
    [Abstract] [Full Text] [Related]

  • 15. Adjuvant Chemotherapy and Radiation Therapy is Associated with Improved Survival for Patients with Extrahepatic Cholangiocarcinoma.
    Hoehn RS, Wima K, Ertel AE, Meier A, Ahmad SA, Shah SA, Abbott DE.
    Ann Surg Oncol; 2015 Dec 15; 22 Suppl 3():S1133-9. PubMed ID: 25976862
    [Abstract] [Full Text] [Related]

  • 16. The impact of portal vein resection on outcomes for hilar cholangiocarcinoma: a multi-institutional analysis of 305 cases.
    de Jong MC, Marques H, Clary BM, Bauer TW, Marsh JW, Ribero D, Majno P, Hatzaras I, Walters DM, Barbas AS, Mega R, Schulick RD, Choti MA, Geller DA, Barroso E, Mentha G, Capussotti L, Pawlik TM.
    Cancer; 2012 Oct 01; 118(19):4737-47. PubMed ID: 22415526
    [Abstract] [Full Text] [Related]

  • 17. Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis.
    Ecker BL, Vining CC, Roses RE, Maggino L, Lee MK, Drebin JA, Fraker DL, Vollmer CM, Datta J.
    Ann Surg Oncol; 2017 Dec 01; 24(13):3926-3933. PubMed ID: 28952140
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The influence of total nodes examined, number of positive nodes, and lymph node ratio on survival after surgical resection and adjuvant chemoradiation for pancreatic cancer: a secondary analysis of RTOG 9704.
    Showalter TN, Winter KA, Berger AC, Regine WF, Abrams RA, Safran H, Hoffman JP, Benson AB, MacDonald JS, Willett CG.
    Int J Radiat Oncol Biol Phys; 2011 Dec 01; 81(5):1328-35. PubMed ID: 20934270
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.